Celgene revenue increased from $13 billion in 2017 to $15.3 billion in 2018, a (17.5%) increase.

Annual Revenue ($)

Celgene revenue was $15.28 b in FY, 2018 which is a (17.5%) year over year increase from the previous period.

Quarterly Revenue ($)

FY, 2016FY, 2017FY, 2018
Revenue$11.23 b$13 b$15.28 b
Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019
Revenue$2.96 b$3.27 b$3.29 b$3.54 b$3.81 b$3.89 b$4.03 b$4.4 b$4.52 b

Annual Growth Rate (%)

Revenue Breakdown

Business Segment

Geographic Segment

Celgene revenue breakdown by business segment: 89.4% from Hematology / Oncology, 10.5% from Inflammation & Immunology and 0.1% from Other

Celgene revenue breakdown by geographic segment: 34.4% from International and 65.6% from U.S.

FY, 2018FY, 2017FY, 2016
Hematology / Oncology$13.66 b$11.69 b$10.17 b
Inflammation & Immunology$1.61 b$1.28 b$1.02 b
Other revenue$16 m$30 m$44 m
FY, 2018FY, 2017FY, 2016
Europe$3.33 b$3.05 b
U.S.$10.02 b$8.32 b$7.01 b
All other$1.35 b$1.17 b
International$5.25 b

Need Data?

Craft can deliver 250+ data points of financial, operating, and human capital indicators on companies via API.

Footer menu